Medical dictionary
Medical terminology normalized via MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
from Eupatorium lindleyanum DC; structure in first source
- C5757503-(hydroxymethyl)-1,13,15-trihydroxy-7,11,15-trimethyl-2,6,10-hexadecatrien-14-yl acetateMeSH
from Eupatorium lindleyanum DC; structure in first source
- C5757493-(hydroxymethyl)-1,14,15-trihydroxy-7,11,15-trimethyl-2,6,10-hexadecatrien-13-yl acetateMeSH
from Eupatorium lindleyanum DC; structure in first source
a TRPV1 antagonist; structure in first source
structure in first source
isolated from Actinomadura miaoliensis; structure in first source
structure in first source
molecular imaging probe for hypoxia-inducible factor-1
a radioprotective agent; structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent.
An enzyme that catalyzes the formation of 7-phospho-2-keto-3-deoxy-D-arabinoheptonate from phosphoenolpyruvate and D-erythrose-4-phosphate. It is one of the first enzymes in the biosynthesis of TYROSINE and PHENYLALANINE. This enzyme was formerly listed as EC 4.1.2.15.
mutation in HMGCS2
Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis.
An NAD-dependent 3-hydroxyacyl CoA dehydrogenase that has broad specificity with regards to the acyl chain length of the substrate.
An enzyme that catalyzes the conversion of 3-hydroxyanthranilate to 2-amino-3-carboxymuconate semialdehyde. It was formerly characterized as EC 1.13.1.6.
An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.
BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids.
A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.
An NAD+ dependent enzyme that catalyzes the oxidation of 3-carboxy-2-hydroxy-4-methylpentanoate to 3-carboxy-4-methyl-2-oxopentanoate. It is involved in the biosynthesis of VALINE; LEUCINE; and ISOLEUCINE.
An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions.
Metabolite of serotonin and norepinephrine.
A ketone oxidoreductase that catalyzes the overall conversion of alpha-keto acids to ACYL-CoA and CO2. The enzyme requires THIAMINE DIPHOSPHATE as a cofactor. Defects in genes that code for subunits of the enzyme are a cause of MAPLE SYRUP URINE DISEASE. The enzyme was formerly classified as EC 1.2.4.3.
an alpha4beta2 nicotinic receptor agonist; structure in first source
structure in first source
from Tephrosia cinerea; structure in first source
- C5751453-O-(3',4'-O-acetyl)-arabinopyranosyl hederagenin 28-O-glucopyranosyl-(1-6)-glucopyranosideMeSH
protects against Abeta(25-35)-induced cytotoxicity; isolated from the roots of Dipsacus asper; structure in first source
- C5749983-O-(4'-O-acetyl)rhamnopyranoside-(I-6,II-8)-kaempferol-3-O-(4'-O-acetyl)rhamnopyranosideMeSH
an iron chelating agent isolated from Zingiber spectabile; structure in first source
- C5784093-O-(6'-O-butyl-beta-D-glucuronopyranosyl)-oleanolic acid-28-O-beta-D-glucopyranosyl esterMeSH
from Alternanthera philoxeroides
from Catharanthus roseus; structure in first source
from Catharanthus roseus; structure in first source
has antineoplastic activity; isolated from Butyrospermum parkii; structure in first source
from Patrinia scabiosifolia; structure in first source
A non-metabolizable glucose analogue that is not phosphorylated by hexokinase. 3-O-Methylglucose is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems. (J Neurochem 1993;60(4):1498-504)
from the leaves and twigs of Radermachera boniana; structure in first source
catalyzes reaction of inorganic phosphate with 3-O-alpha-D-glucopyranosyl-L-rhamnose to yield beta-D-glucose-1-phosphate and rhamnose
from Anemone taipaiensis; structure in first source
protects against Abeta(25-35)-induced cytotoxicity; isolated from the roots of Dipsacus asper; structure in first source
protects against Abeta(25-35)-induced cytotoxicity; isolated from the roots of Dipsacus asper; structure in first source